Novel lymphocyte growth-inhibiting tripeptide: N-acetyl-glu-ser-GlyNH(2)

Biochem Biophys Res Commun. 2000 Nov 2;277(3):562-7. doi: 10.1006/bbrc.2000.3666.

Abstract

The limited and predetermined number of cells that constitutes an organ or specialized cell population is to all appearances regulated according to a negative feedback principle involving growth inhibitors with sufficient tissue specificity. To find growth-inhibiting factors in lymphoid cells, we followed established purification procedures and assays. We found a single-peak fraction in water extracts of dog spleen homogenates that inhibited proliferation of Molt (T cell) lymphoma cells at low concentrations in vitro, with no significant effect on a B cell lymphoma cell line (Ramos). C-terminal amino acid sequencing and MS analysis showed the factor to be a tripeptide: N-acetyl-Glu-Ser-GlyNH(2). Treatment with a synthetic tripeptide with the structure N-acetyl-Glu-Ser-GlyNH(2) decreased the number of cell doublings of Molt cells. The peptide also delayed cell flux at the G(2)-M transition of the cell cycle, while incorporation of tritiated thymidine was not altered at the examined time points in this cell line. However, DNA synthesis in PPD-stimulated normal human lymphocytes was significantly inhibited and with a bell-shaped dose-response curve.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / isolation & purification
  • Antineoplastic Agents / pharmacology*
  • Cell Cycle / drug effects
  • Cell Division / drug effects
  • Dogs
  • Humans
  • Lymphocytes / cytology
  • Lymphocytes / drug effects*
  • Oligopeptides / pharmacology*
  • Peptides / isolation & purification
  • Peptides / pharmacology
  • Sequence Analysis, Protein
  • Spleen / chemistry
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • N-acetylglutamyl-seryl-glycinamide
  • Oligopeptides
  • Peptides